Pigmented progressive purpuric dermatosis https://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
https://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
☆ AI Dermatology — Free ServiceEmiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.  - Schamberg disease ― owesilisa oneminyaka engu-26 ubudala onobala le-asymptomatic pigmentation kanye ne-telangiectasia emlenzeni. 
relevance score : -100.0%
References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260
 Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 NIH
Pigmented purpuric dermatoses (PPD) ziyiqembu lezimo zesikhumba ezimaka izindawo ezincane zokopha ngaphansi kwesikhumba ngenxa yokuvuvukala kwamacapillary. I-PPD ivamise ukuqala ngokubomvu kuya kokunsomi, bese ngokuhamba kwesikhathi kuba nsundu noma golide njengoba i-hemosiderin imuncwa kabusha.
Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
 Schamberg Disease 32809367
 Schamberg Disease 32809367 NIH
i-Schamberg disease iwuhlobo oluvame kakhulu lwe-pigmented purpuric dermatoses (PPDs), okuyizimo zesikhumba ezingalapheki ezibonakala ngamachashaza amancane abomvu noma ansomi, nokwanda kombala wesikhumba (amabala ansundu, abomvu noma aphuzi). Ama-PPD ahlukaniswa ngezinhlobo ezinhlanu: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot‑Blum purpura, eczematoid‑like purpura of Doucas and Kapetanakis. Schamberg disease (SD) yaziwa nangokuthi progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. Ihlasela kakhulu abesilisa futhi ngokuvamile ivela emilenzeni engezansi, kodwa ingase yenzeke emathangeni, ezinqeni, esiqwini noma ezingalweni.
Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
 Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156
 Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 NIH
Ulwazi ngeziguli ezingu-113 ezine-PPD lwahlaziywa, okuhlanganisa ama-38 ahlolwe ngesikhumba kulolu cwaningo. Uhlobo lomtholampilo oluvame kakhulu kwakuyisifo sikaSchamberg (60.5%). Ezinye izimo ezihambisana ne-PPD kwakuyi-hypertension (15.8%), isifo sikashukela (10.5%) nezinye. Umlando wemithi wembula ukusetshenziswa kwama-statins (13.2%), ama-beta blockers (10.5%) namanye. Izici ezivame ukuhambisana ne-PPD zihlanganisa ukutheleleka kokuphefumula okuphezulu (5.3%), ukuma isikhathi eside okuholela ekucindezelweni okuphezulu kwe-orthostatic (2.6%) nokuzivocavoca okunzima (2.6%). Ukwelashwa kwenziwe ezigulini ezingu-36 (94.7%) – oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
 
○ Ukwelashwa – Izidakamizwa ze‑OTC
I‑OTC steroid ointment
#Hydrocortisone ointment
#Hydrocortisone cream